Smith & Nephew PLC (SNN)
25.14
+0.10
(+0.40%)
USD |
NYSE |
Nov 22, 10:56
Smith & Nephew Total Liabilities (Quarterly): 5.337B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.337B |
| June 30, 2024 | 5.337B |
| December 31, 2023 | 4.77B |
| June 30, 2023 | 4.611B |
| June 30, 2023 | 4.611B |
| December 31, 2022 | 4.707B |
| June 30, 2022 | 4.71B |
| June 30, 2022 | 4.71B |
| December 31, 2021 | 5.352B |
| June 30, 2021 | 5.602B |
| June 30, 2021 | 5.602B |
| December 31, 2020 | 5.733B |
| June 30, 2020 | 4.579B |
| June 30, 2020 | 4.579B |
| December 31, 2019 | 4.158B |
| June 30, 2019 | 3.994B |
| June 30, 2019 | 3.994B |
| December 31, 2018 | 3.185B |
| June 30, 2018 | 3.07B |
| June 30, 2018 | 3.07B |
| December 31, 2017 | 3.222B |
| June 30, 2017 | 3.238B |
| June 30, 2017 | 3.238B |
| December 31, 2016 | 3.386B |
| June 30, 2016 | 3.558B |
| Date | Value |
|---|---|
| June 30, 2016 | 3.558B |
| December 31, 2015 | 3.201B |
| June 30, 2015 | 3.166B |
| June 30, 2015 | 3.166B |
| December 31, 2014 | 3.266B |
| September 30, 2014 | 3.633B |
| June 30, 2014 | 3.587B |
| June 30, 2014 | 3.587B |
| March 31, 2014 | 1.724B |
| December 31, 2013 | 1.772B |
| September 30, 2013 | 1.656B |
| June 30, 2013 | 1.557B |
| March 31, 2013 | 1.512B |
| December 31, 2012 | 1.758B |
| September 30, 2012 | 1.355B |
| June 30, 2012 | 1.255B |
| March 31, 2012 | 1.431B |
| December 31, 2011 | 1.56B |
| September 30, 2011 | 1.764B |
| June 30, 2011 | 1.776B |
| March 31, 2011 | 1.787B |
| December 31, 2010 | 1.96B |
| September 30, 2010 | 2.40B |
| June 30, 2010 | 2.273B |
| March 31, 2010 | 2.309B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.158B
Minimum
Dec 2019
5.733B
Maximum
Dec 2020
4.960B
Average
4.71B
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Haleon PLC | 21.11B |
| Adaptimmune Therapeutics PLC | 237.45M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Verona Pharma PLC | 251.33M |
| NuCana PLC | 20.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.54B |
| Shareholders Equity (Quarterly) | 5.205B |
| Debt to Equity Ratio | 0.6669 |
| Current Ratio | 2.509 |
| Net Debt Paydown Yield | -2.45% |